{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-12-07T12:21:11.139504+00:00",
  "news": [
    {
      "title": "Down 10%, Should You Buy the Dip on Vertex Pharmaceuticals? - Nasdaq",
      "link": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxQdkNxRlVib3NYOHYzbXY5LUlmNFpCQUlyTUc1b2Y3SE9XWWdXUTBqcEY2clNpOVRnekxsMTROSjZuTHBoLVp1dkh1WEVVLV9HLWZnTWNhN0hUR2xFN3E4NmVtQUVZeUdJUW1VNi0tbzZFVkFpR3RKMFRqZmJjMGZuWHppb00tLUR5?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQdkNxRlVib3NYOHYzbXY5LUlmNFpCQUlyTUc1b2Y3SE9XWWdXUTBqcEY2clNpOVRnekxsMTROSjZuTHBoLVp1dkh1WEVVLV9HLWZnTWNhN0hUR2xFN3E4NmVtQUVZeUdJUW1VNi0tbzZFVkFpR3RKMFRqZmJjMGZuWHppb00tLUR5?oc=5\" target=\"_blank\">Down 10%, Should You Buy the Dip on Vertex Pharmaceuticals?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
      "published": "2025-12-07T01:15:00+00:00",
      "source": "Nasdaq"
    },
    {
      "title": "Down 10%, Should You Buy the Dip on Vertex Pharmaceuticals? - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPY2d6X1piMmhPM010UzdSMndVTVdiSVRBQnpCTkhTZ25hekR1S3I5SDBiVGlkdXJoNk1WbDJNQWRNcEJ2OTRYTkZlTzFxYkxzMTZEVnYxcnpzRGRmZTBtZkgza3NWb1VmbWlSbTIyMHVGWTVjNFJLM21DOENRSWdsX0FZdVRWZUk3S0tLb2FZeEp2ak9nQlJOUw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxPY2d6X1piMmhPM010UzdSMndVTVdiSVRBQnpCTkhTZ25hekR1S3I5SDBiVGlkdXJoNk1WbDJNQWRNcEJ2OTRYTkZlTzFxYkxzMTZEVnYxcnpzRGRmZTBtZkgza3NWb1VmbWlSbTIyMHVGWTVjNFJLM21DOENRSWdsX0FZdVRWZUk3S0tLb2FZeEp2ak9nQlJOUw?oc=5\" target=\"_blank\">Down 10%, Should You Buy the Dip on Vertex Pharmaceuticals?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2025-12-07T00:15:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Marshall Wace LLP Has $52.09 Million Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxNeWhqS2RzazlKY3U2RmxoU3o4WFdMYU1yTE42ZVhIRkNqR054dldwS0JfMkFlSU0zUDBvWGpFRk5kOG51ckJmS1h5S2lseTA0amRXY3diclBQcXU0U2ItTmpvQzUzekJwMEwyLWRfSHVPWWVqaGdpNjlMcm9CWDFhRHhRSVJfZHo1V0VKa2ZhNFB6SEJscnlUbzZsaG9iTzFDSUpESDd5X0JJVTh4Q0ZFNUx6NUlONjdmZlVDaThBS3FzZGZGb0VOcEhmbDJTNkxfbk5CRUFxdzdRMkFPRXVQdjJR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi4gFBVV95cUxNeWhqS2RzazlKY3U2RmxoU3o4WFdMYU1yTE42ZVhIRkNqR054dldwS0JfMkFlSU0zUDBvWGpFRk5kOG51ckJmS1h5S2lseTA0amRXY3diclBQcXU0U2ItTmpvQzUzekJwMEwyLWRfSHVPWWVqaGdpNjlMcm9CWDFhRHhRSVJfZHo1V0VKa2ZhNFB6SEJscnlUbzZsaG9iTzFDSUpESDd5X0JJVTh4Q0ZFNUx6NUlONjdmZlVDaThBS3FzZGZGb0VOcEhmbDJTNkxfbk5CRUFxdzdRMkFPRXVQdjJR?oc=5\" target=\"_blank\">Marshall Wace LLP Has $52.09 Million Position in Vertex Pharmaceuticals Incorporated $VRTX</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-12-07T11:11:32+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Why Vertex Pharmaceuticals (VRTX) Stock Is Up Today - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxOSXhlZWF3d2dOc1pnaDYtSUVSX3ZLMzR2SnN1SnlyWUxRUXdwQW4zNU5tYldCSXBxQ1F0Mlh1ZHp6cm1pX2FMRDhiNUtOSWZxek5uRzlsX3dHV3puclVOSnVQNWVZOFlDTHEzb1pZLXA1UWxVSUxLS1VQV3lNQWhRWGlNd2RERDRqcWlj?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOSXhlZWF3d2dOc1pnaDYtSUVSX3ZLMzR2SnN1SnlyWUxRUXdwQW4zNU5tYldCSXBxQ1F0Mlh1ZHp6cm1pX2FMRDhiNUtOSWZxek5uRzlsX3dHV3puclVOSnVQNWVZOFlDTHEzb1pZLXA1UWxVSUxLS1VQV3lNQWhRWGlNd2RERDRqcWlj?oc=5\" target=\"_blank\">Why Vertex Pharmaceuticals (VRTX) Stock Is Up Today</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-12-03T19:11:29+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex's gene therapy shows promise in younger children with blood disorders - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxOWThkMTFHZl8tQWdvbG5ieUpBMHlYdVI1RVhSbmFFNmVTMlBxeWkxQ1VWVkRnR0ZZV2NQYnJIN29oTEU4ck1ubHRJbHpyT0c4UVF1UkV4S0s0UmV2Y183LWJNS2twNHNDY3RYYXBDUGJES0Vwb0s2UHRxSXlDV0ZDcXpXOWJNN0pyc0JudDF2Z0ZIT3RhMHNVOC1pcENwODFBdUozY1lqbzJ2Q0tpZHpfZVpvcTFHa3BfSGZPdHR6bUh3Z2xpSUpFWTgwQXhKcWFJVzdKZlROSExyZUNz?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi3AFBVV95cUxOWThkMTFHZl8tQWdvbG5ieUpBMHlYdVI1RVhSbmFFNmVTMlBxeWkxQ1VWVkRnR0ZZV2NQYnJIN29oTEU4ck1ubHRJbHpyT0c4UVF1UkV4S0s0UmV2Y183LWJNS2twNHNDY3RYYXBDUGJES0Vwb0s2UHRxSXlDV0ZDcXpXOWJNN0pyc0JudDF2Z0ZIT3RhMHNVOC1pcENwODFBdUozY1lqbzJ2Q0tpZHpfZVpvcTFHa3BfSGZPdHR6bUh3Z2xpSUpFWTgwQXhKcWFJVzdKZlROSExyZUNz?oc=5\" target=\"_blank\">Vertex's gene therapy shows promise in younger children with blood disorders</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-12-06T12:04:29+00:00",
      "source": "Reuters"
    },
    {
      "title": "Vertex CRISPR therapy hits early goal in children with blood disorders - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPa2ItUVA2YzZOSWN0WV85QmE3ZVhPLXZ0ZlRvR3JYMlNUcGpqbXNhYkk1cjBuMlVBenplRWp5OUxBY29ZMDZYQ2NCWHg4a0kta1RQcmFRVzlvSXVyTzkxNlVHZ181aWxmcFdpbE1BMEd0YUp4U0k1U3QzeEFKXy16cGR2aHMzaFR2ODVwTEhMTFQ2dDFUVC0yZQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxPa2ItUVA2YzZOSWN0WV85QmE3ZVhPLXZ0ZlRvR3JYMlNUcGpqbXNhYkk1cjBuMlVBenplRWp5OUxBY29ZMDZYQ2NCWHg4a0kta1RQcmFRVzlvSXVyTzkxNlVHZ181aWxmcFdpbE1BMEd0YUp4U0k1U3QzeEFKXy16cGR2aHMzaFR2ODVwTEhMTFQ2dDFUVC0yZQ?oc=5\" target=\"_blank\">Vertex CRISPR therapy hits early goal in children with blood disorders</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-12-06T13:24:13+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Morgan Stanley upgrades Vertex stock to Overweight on kidney pipeline potential - Investing.com",
      "link": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNM01TaGRFQTMtcV9GdkpSZm1lZzhPQlBIeFdFWXBiemlHb0Y1MDBCNXMweE5WYjhsZG9ZNW5kVWJ1VHJKWHVEdzRVUTFJN2ZUMG16MWJEZEZxblJLSklSMHItN2VRQ2UwdXFIR3J2RElkZVJLbm9zVkRIUFZNZXJMZ1dJNDhpMmg2ajBEelBwMHByWlFldDgzNlpaS2RZYW5TTm10ajd5aDVPUUhVZGNMNzRzUDh1OUNsS0lIdmhOM2dTeVNPRVhzR0FyRDVsaUVUeU5Sd0dB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1gFBVV95cUxNM01TaGRFQTMtcV9GdkpSZm1lZzhPQlBIeFdFWXBiemlHb0Y1MDBCNXMweE5WYjhsZG9ZNW5kVWJ1VHJKWHVEdzRVUTFJN2ZUMG16MWJEZEZxblJLSklSMHItN2VRQ2UwdXFIR3J2RElkZVJLbm9zVkRIUFZNZXJMZ1dJNDhpMmg2ajBEelBwMHByWlFldDgzNlpaS2RZYW5TTm10ajd5aDVPUUhVZGNMNzRzUDh1OUNsS0lIdmhOM2dTeVNPRVhzR0FyRDVsaUVUeU5Sd0dB?oc=5\" target=\"_blank\">Morgan Stanley upgrades Vertex stock to Overweight on kidney pipeline potential</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investing.com</font>",
      "published": "2025-12-03T10:28:02+00:00",
      "source": "Investing.com"
    },
    {
      "title": "Vertex presents new data on Casgevy at ASH - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPNWZkS1kzRnN0UHdKbjlYYWd1ckI2R3NzWk4wVlJsZkdfNldKTUxFQzUwWEM3d0JpQU5PYlZ4cFpnNEpaZ2RfYmRhZXhfcWxjNTY4S3haM1A1RHJveG43Q3A5MnRUSDhDNU9QZTZOOURST2JRekVVZW1DUFVDTUx4Z18xS1RtellRdmM5enZPMUdmdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikgFBVV95cUxPNWZkS1kzRnN0UHdKbjlYYWd1ckI2R3NzWk4wVlJsZkdfNldKTUxFQzUwWEM3d0JpQU5PYlZ4cFpnNEpaZ2RfYmRhZXhfcWxjNTY4S3haM1A1RHJveG43Q3A5MnRUSDhDNU9QZTZOOURST2JRekVVZW1DUFVDTUx4Z18xS1RtellRdmM5enZPMUdmdw?oc=5\" target=\"_blank\">Vertex presents new data on Casgevy at ASH</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-12-06T14:52:08+00:00",
      "source": "The Pharma Letter"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex’s new pain, blood disorder drugs miss Wall Street expectations - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5\" target=\"_blank\">Vertex’s new pain, blood disorder drugs miss Wall Street expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Vertex’s New Products Dim as Analysts Eye Kidney Portfolio - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5\" target=\"_blank\">Vertex’s New Products Dim as Analysts Eye Kidney Portfolio</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-12-05",
      "close": 455.4800109863281
    },
    "history": [
      {
        "date": "2025-11-26",
        "close": 432.1700134277344
      },
      {
        "date": "2025-11-28",
        "close": 433.6099853515625
      },
      {
        "date": "2025-12-01",
        "close": 425.6000061035156
      },
      {
        "date": "2025-12-02",
        "close": 433.1499938964844
      },
      {
        "date": "2025-12-03",
        "close": 463.1300048828125
      },
      {
        "date": "2025-12-04",
        "close": 457.3599853515625
      },
      {
        "date": "2025-12-05",
        "close": 455.4800109863281
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}